Scholarlink

Background <p>Gastroesophageal variceal bleeding is a life-threatening complication of portal hypertension. This study evaluated the efficacy and safety of endoscopic ultrasound-guided selective variceal devascularization (EUS-SVD) compared with conventional endoscopic cyanoacrylate injection.</p> Methods <p>This retrospective cohort study adhered to the STROBE guidelines. Between August 2022 and June 2024, 107 patients were enrolled and allocated to conventional endoscopy (<i>n</i> = 52) or EUS-SVD (<i>n</i> = 55). Propensity score matching was performed to reduce confounding. Primary outcomes included rebleeding, ulcer formation, and resource utilization.</p> Results <p>Compared with the conventional group, the EUS group required significantly lower volumes of polidocanol and cyanoacrylate (both <i>P</i> &lt; 0.05). The 6‑month rebleeding rate and 3‑month ulcer formation rate were significantly lower in the EUS group (<i>P</i> &lt; 0.05). Kaplan-Meier analysis demonstrated a reduced cumulative rebleeding incidence in the EUS group (HR 0.38, 95%CI 0.17–0.86, <i>P</i> = 0.021).</p> Conclusions <p>Within the limitations of a single-center retrospective design, these findings suggest that EUS-SVD may represent a promising therapeutic option for gastroesophageal varices, although it requires validation in prospective randomized trials.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The efficacy and safety of endoscopic ultrasound selective variceal devascularization for the treatment of esophagogastric varices: a retrospective cohort study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月23日

查看全文
  • Chengqi Guan,
  • Fan Huang,
  • Hongyuan Shen,
  • Wei Huang,
  • Yachen Wang,
  • Zhenbiao Mao,
  • Cuihua Lu,
  • Jian Feng Zhang

摘要

Background

Gastroesophageal variceal bleeding is a life-threatening complication of portal hypertension. This study evaluated the efficacy and safety of endoscopic ultrasound-guided selective variceal devascularization (EUS-SVD) compared with conventional endoscopic cyanoacrylate injection.

Methods

This retrospective cohort study adhered to the STROBE guidelines. Between August 2022 and June 2024, 107 patients were enrolled and allocated to conventional endoscopy (n = 52) or EUS-SVD (n = 55). Propensity score matching was performed to reduce confounding. Primary outcomes included rebleeding, ulcer formation, and resource utilization.

Results

Compared with the conventional group, the EUS group required significantly lower volumes of polidocanol and cyanoacrylate (both P < 0.05). The 6‑month rebleeding rate and 3‑month ulcer formation rate were significantly lower in the EUS group (P < 0.05). Kaplan-Meier analysis demonstrated a reduced cumulative rebleeding incidence in the EUS group (HR 0.38, 95%CI 0.17–0.86, P = 0.021).

Conclusions

Within the limitations of a single-center retrospective design, these findings suggest that EUS-SVD may represent a promising therapeutic option for gastroesophageal varices, although it requires validation in prospective randomized trials.